Taken together, these findings are in accord with studies that have consistently identified that CAMKK2 was overexpressed in human prostate tumor biopsies [9,43], highlighting the significance of AR-CAMKK2-AMPK signaling in mediating energy metabolism in prostate cancer. Here, AR is linked to prostate carcinoma.